Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Socially Isolated Older Adults Living With Dementia [NA]
A completed clinical trial evaluating social isolation interventions for older adults living with dementia and Alzheimer disease, with resul…
-
CLINICAL_TRIALS trial_result · 2022-01-21Clinical Trial Update: Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance [Phase 2]
Phase 2 trial of azeliragon in mild Alzheimer's disease with impaired glucose tolerance was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Testing Tele-Savvy, an On-line Psychoeducation Program for Dementia Family Caregivers [NA]
A completed clinical trial evaluating Tele-Savvy, an online psychoeducation program for dementia family caregivers; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-06Clinical Trial Update: Effect of Hydralazine on Alzheimer's Disease [Phase 3]
Phase 3 clinical trial investigating the effect of hydralazine on Alzheimer's disease is currently in an unknown status.
-
CLINICAL_TRIALS trial_result · 2021-12-30Clinical Trial Update: Alzheimer's Disease Long-term Follow-up Study (ALF Study) [Phase 4]
Phase 4 long-term follow-up study update for Alzheimer’s disease completed; no new results provided in snippet.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: Trial of Rifaximin in Probable Alzheimer's Disease [Phase 2]
Phase 2 trial of rifaximin in probable Alzheimer's disease has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-16Clinical Trial Update: Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's [NA]
A terminated clinical trial investigating low-dose radiotherapy to reduce cerebral amyloidosis in early Alzheimer's disease; results posted …
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease [Phase 3]
Phase 3 trial of gantenerumab in prodromal Alzheimer's disease completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update for amyloid-beta PET imaging tracer 18F-92 in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2021-12-03Clinical Trial Update: Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Nilotinib BE in early Alzheimer's disease is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease [Phase 2]
Phase 2 study evaluating AVP-923 (dextromethorphan/quinidine) for agitation in Alzheimer's disease completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers [EARLY_Phase 1]
Phase 1 trial update for I2PETHV investigating Imidazoline2 binding site in healthy volunteers; results posted for an early phase study.
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease [Phase 3]
Phase 3 trial update for ALZT-OP1 in early Alzheimer's disease with completed status.
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: Neural Correlates In Mild Alzheimer's Disease [Phase 4]
Phase 4 clinical trial update examining neural correlates in mild Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: A Study of the Biodistribution and Safety of [18F]GTP1 in Healthy Japanese Participants [Phase 1]
Phase 1 trial evaluating biodistribution and safety of a radiotracer [18F]GTP1 in healthy Japanese participants; completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease [Phase 2]
A Phase 2 proof-of-concept study evaluating the selective p38 MAPK alpha inhibitor neflamapimod in adults with mild Alzheimer's disease has …
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease [Phase 2]
Phase 2 safety study of R(+)Pramipexole for early Alzheimer's disease completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Riluzole in Mild Alzheimer's Disease [Phase 2]
Phase 2 trial evaluating riluzole in mild Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities [Phase 2]
Phase 2 trial update evaluating safety of continued aducanumab dosing in participants with asymptomatic amyloid-related imaging abnormalitie…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Optimizing Dementia Care [NA]
Clinical trial update for optimizing dementia care has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Care Ecosystem: Navigating Patients and Families Through Stages of Care [NA]
Clinical trial update for Care Ecosystem study assessing navigation through stages of care for dementia and related disorders; study complet…
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease [Phase 3]
Phase 3 study update for aducanumab (BIIB037) in early Alzheimer's disease; trial terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease [Phase 3]
Phase 3 trial update for aducanumab (BIIB037) in early Alzheimer's disease; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: NMDA Enhancer for the Treatment of Mild Alzheimer's Disease [Phase 2]
Phase 2 trial update for a NMDA enhancer evaluated for mild Alzheimer's disease has completed enrollment and status.
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Treatment of Psychosis and Agitation in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update reporting results for treating psychosis and agitation in Alzheimer's disease. The study is completed and resu…